Richard G Langley Selected Research

Richard G Langley Research Topics

Disease

76	Psoriasis (Pustulosis Palmaris et Plantaris) 12/2023 - 12/2003
11	Infections 11/2023 - 06/2007
7	Atopic Dermatitis (Atopic Eczema) 12/2024 - 02/2002
6	Inflammation (Inflammations) 12/2023 - 01/2006
6	Neoplasms (Cancer) 01/2023 - 10/2011
4	Skin Diseases (Skin Disease) 12/2023 - 05/2007
4	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023 - 07/2016
4	Body Weight (Weight, Body) 06/2022 - 01/2008
4	Oral Candidiasis (Thrush) 03/2022 - 01/2021
3	Pain (Aches) 12/2024 - 01/2007
3	Ulcerative Colitis 01/2023 - 03/2017
3	Crohn Disease (Crohn's Disease) 01/2023 - 03/2017
3	Skin Neoplasms (Skin Cancer) 01/2023 - 02/2012
3	Eczema 11/2022 - 05/2005
3	Psoriatic Arthritis 01/2018 - 10/2005
2	Pruritus (Itching) 12/2024 - 01/2007
2	Myocardial Infarction 09/2023 - 08/2011
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2023 - 02/2012
2	Hypertension (High Blood Pressure) 01/2021 - 07/2012
2	Neutropenia 07/2016 - 10/2015
1	Tuberculosis (Tuberculoses) 01/2023
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023
1	Opportunistic Infections (Opportunistic Infection) 01/2023
1	Mycoses (Diseases, Fungus) 03/2022
1	Chronic Disease (Chronic Diseases) 01/2022
1	Diarrhea 01/2021
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2021
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2018
1	Candidiasis (Moniliasis) 10/2015
1	Cardiovascular Diseases (Cardiovascular Disease) 12/2014
1	Tetanus 10/2013
1	Hyperlipidemias (Hyperlipidemia) 07/2012
1	Stroke (Strokes) 08/2011
1	Nasopharyngitis 04/2011
1	Lymphopenia (Lymphocytopenia) 07/2010
1	Chills 07/2010
1	Headache (Headaches) 07/2010
1	Melanoma (Melanoma, Malignant) 01/2008
1	Cryopyrin-Associated Periodic Syndromes 01/2008

Drug/Important Bio-Agent (IBA)

17	Ustekinumab (CNTO 1275)FDA Link 10/2023 - 05/2008
15	Etanercept (Enbrel)FDA Link 01/2018 - 01/2006
14	Monoclonal AntibodiesIBA 10/2023 - 02/2007
11	InterleukinsIBA 12/2023 - 05/2008
11	CytokinesIBA 12/2023 - 09/2005
11	secukinumabIBA 10/2023 - 07/2014
10	Interleukin-17 (Interleukin 17)IBA 10/2023 - 07/2014
10	Adalimumab (Humira)FDA Link 01/2021 - 10/2006
9	guselkumabIBA 10/2023 - 01/2018
8	Interleukin-12 (IL 12)IBA 07/2012 - 02/2007
7	Interleukin-23 (Interleukin 23)IBA 12/2023 - 08/2011
7	bimekizumabIBA 11/2023 - 01/2021
7	Infliximab (Remicade)FDA Link 01/2021 - 01/2006
6	Immunoglobulin A (IgA)IBA 03/2023 - 01/2019
5	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 09/2009
5	briakinumabIBA 02/2012 - 02/2008
4	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2024 - 09/2005
4	Alefacept (Amevive)FDA Link 09/2009 - 12/2003
4	efalizumab (Raptiva)FDA Link 09/2009 - 01/2006
3	risankizumabIBA 09/2023 - 01/2020
3	omega-Chloroacetophenone (Mace)IBA 01/2023 - 08/2011
3	AntibodiesIBA 01/2019 - 05/2007
3	ixekizumabIBA 01/2018 - 07/2016
3	Prostaglandins AIBA 02/2012 - 10/2004
3	pimecrolimus (Elidel)FDA Link 09/2005 - 02/2002
2	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 11/2023 - 08/2012
2	Interleukin-23 Subunit p19IBA 09/2023 - 08/2021
2	tralokinumabIBA 11/2022 - 10/2022
2	brodalumabIBA 01/2018 - 10/2015
2	siplizumabIBA 07/2010 - 07/2009
2	Immunosuppressive Agents (Immunosuppressants)IBA 09/2009 - 10/2005
2	Therapeutic UsesIBA 09/2009 - 10/2004
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2008 - 10/2006
2	Tacrolimus (Prograf)FDA LinkGeneric 05/2005 - 02/2002
2	Ointments (Pastes)IBA 05/2005 - 02/2002
1	upadacitinibIBA 12/2024
1	Interleukin-13IBA 12/2023
1	Phosphodiesterase 4 InhibitorsIBA 12/2023
1	Alanine Transaminase (SGPT)IBA 11/2023
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 11/2023
1	mirikizumabIBA 09/2023
1	Tumor Necrosis Factor InhibitorsIBA 01/2021
1	tofacitinibIBA 05/2016
1	Janus Kinase InhibitorsIBA 05/2016
1	VaccinesIBA 10/2013
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 10/2013
1	apremilastIBA 08/2012
1	6-chloro-2-(1-piperazinyl)pyrazine (CPP)IBA 08/2011
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2010
1	RetinoidsIBA 09/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2009
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2008
1	HLA-G Antigens (HLA G)IBA 01/2008

Therapy/Procedure

28	Therapeutics 01/2023 - 02/2002
7	Phototherapy (Light Therapy) 01/2022 - 09/2004
7	Biological Therapy 01/2021 - 07/2009
2	Duration of Therapy 01/2021 - 11/2017
1	Oral Hygiene (Dental Hygiene) 03/2022
1	Tattooing 07/2012
1	Retreatment 02/2011
1	Subcutaneous Injections 01/2008